Neuropsychiatric features of current COVID-19 pandemic (analysis of foreign publications in 2020)
https://doi.org/10.33667/2078-5631-2020-33-58-61
Abstract
The article presents a review of the scientific literature containing data on the features of neuropsychiatric disorders – complications from the nervous system against the background of viral load caused by SARS-CoV-2 COVID-19. Indirect effects of the virus such as encephalopathy, myopathy, and critical neuropathy can be caused by hypoxia, respiratory and metabolic acidosis, dysregulation of homeostasis due to organ failure, and autoimmune inflammatory and demyelinating processes. Binding to the receptors of APF2, which is a cardiovascular protection factor for various organs, the nervous system and skeletal muscles is a target for various types of coronaviruses, including SARS-CoV-2 can cause an increase in blood pressure- the main risk factor for ONMC. Thus, prospective neuropsychiatric monitoring of people exposed to SARS-CoV-2 at various stages of the life cycle, as well as their neuroimmune status, is necessary to fully understand the long-term impact of COVID-19 and to provide a basis for integrating psychoneuroimmunology into epidemiological studies of pandemics.
About the Authors
P. G. Madonov
Novosibirsk State Medical University
Russian Federation
Novosibirsk
Russian Federation
Novosibirsk
L. D. Khidirova
Novosibirsk State Medical University
Russian Federation
Novosibirsk
Russian Federation
Novosibirsk
D. A. Derisheva
Novosibirsk State Medical University
Russian Federation
Novosibirsk
Russian Federation
Novosibirsk
References
1. Jonathan P., Edward C., Dominic O., et al. Рsychiatric and neuropsychiatric manifestations associated with severe coronavirus infections: a systematic review and meta-analysis compared to the COVID-19 pandemic Meta-Analysis Lancet psychiatry 2020 Jul; 7 (7): 611–627. DOI: 10.1016/s2215–0366(20)30203–0. Epub 2020 May 18.
2. Mao, R., Liang, J., Shen J., Ghosh S., Zhu L.-R., Yang H., et al. Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol Hepatol. 2020; 5 (5): 425–27. doi:10.1016/S2468–1253(20)30076–5
3. Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., et al. (2020). Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm. Sin. B 10, 766–788. DOI: 10.1016/j.apsb.2020.02.008.
4. Zubair S. et al. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019 by Adeel in JAMA Neurology. Published online May 2020. DOI: 10.1001/jamaneurol.2020.2065.
5. Ye M, Ren Y, Lv T. Encephalitis as a clinical manifestation of COVID-19 [published online ahead of print, 2020 Apr 10]. Brain Behav Immun. 2020; S 08891591(20)30465–7.2020; 10.1212/WNL.0000000000009848.
6. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus. The authors declare no disease 2019 in Wuhan, China [published online ahead of print, 2020 Apr 10]. JAMA Neurol. 2020; 77 (6): 1–9.
7. Natali M., Zubair S. et al. Distribution of the ‘entrance gate’ in the brain for the new SARS-CoV-2 coronavirus – angiotensin-converting enzyme 2 (ACE 2) receptors. Credit: Adeel / JAMA Neurology 2020.
8. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.
9. Chen C, Zhou Y, Wang DW. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. 2020; 10.1007/s00059–020–04909-z. DOI: 10.1007/s00059–020–04909-z.
10. Yang, Y., Peng, F., Wang, R., Guan, K., Jiang, T., Xu, G., Sun, J., Chang, C., 2020 The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. Journal of Autoimmunity 102434. DOI: 10.1016/j.jaut.2020.102434.
11. Assiri A., Al-Tawfiq J.A., Al-Rabeeah A.A. et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect. Dis. 2013. Vol. 13, N 9. P. 752–761. DOI: 10.1016/S1473–3099(13)70204–4.
12. Zeppegno, P., Gramaglia, C., Guerriero, C., Madeddu, F., & Calati, R. (2020, May 17). Psychological/psychiatric impact of the novel coronavirus outbreak: lessons learnt from China and call for timely crisis interventions in Italy. doi:10.31234/osf.io/z26yk
13. Huang C, Wang Y, Li X, Ren L, et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan. Lancet China. doi:10.1016/S0140–6736(20)30183–5.
14. Yakhontov D. A. Introduction to evidence-based medicine [Electronic resource]: textbook / D. A. Yakhontov; ed.– Novosibirsk: Sibmedia the ngma, 2006.– 105 http://library.ngmu.ru/search/view?mfn=23123&irbisBase=MAIN.
15. Novohatsky A. V. Principles of evidence-based medicine in clinical psychology: a modern approach to making objective clinical decisions. Bulletin Of SUSU Psychology; 2010; 17 (6): 85–89 https://cyberleninka.ru/article/n/printsipy-dokazatelnoy-meditsiny-v-klinicheskoy-psihologii-sovremennyy-podhod-k-prinyatiyu-obektivnyh-klinicheskih-resheniy.
16. Asadi-Pooya, AA, Simani, L. Central nervous system manifestations of COVID-19: a systematic review. J Neurol Sci. 2020; 413: 116832. DOI: 10.1016/j.jns.2020.116832.
17. Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S, Manson J. J. COVID-19: consider cytokine storm syndromes and immunosupression. Lancet. 2020; 395 (10229): 1033–34. doi:10.1016/S0140–6736(20)30628–0.
18. Zhang W., Du R. H., Li B., Xu D., Wang J., Li Z., Lin J. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect 2020; 9 (1): 386–9. doi:10.1080/22221751.2020.1729071
19. Mikkelsen, M. D., Naur, P. and Halkier, B. A. (2012). Arabidopsis mutants in theC-S lyase of glucosinolate biosynthesis establish a critical role for indole-3-acetaldoxime in auxin homeostasis. Plant J. 37, 770–777.
20. Luo et al. J Zhejiang Univ-Sci A (Appl Phys & Eng) 2014, 15 (8): 593–605. DOI: 10.1631/jzus.A1400111.
21. Hu, Z., Song, C., Xu, C., Jin, G., Chen, Y., Xu, X., Ma, H., Chen, W., Lin, Y., Zheng, Y., et al. (2020). Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci China Life Sci 63, 706–711. https://doi.org/10.1007/s11427–020–1661–4
22. Erin T. Kaseda & Andrew J. Levine (2020) Post-traumatic stress disorder: A differential diagnostic consideration for COVID-19 survivors. The Clinical Neuropsychologist, 34: 7–8, 1498–1514. DOI: 10.1080/13854046.2020.1811894.
23. Statsenko O. A. clinical case of acute transient psychosis against the background of the COVID-19 pandemic. Omsk Psychiatric Journal. 2020; 2 (24): 23–29 (in Russ) DOI: 10.24411/2412–8805–2020–10204.
24. Quan Y, Huang A, Ye M, Xu M, Zhuang B, Zhang P, Yu B, Min Z. Efficacy of laparoscopic mini gastric bypass for obesity and type 2 diabetes mellitus: a systematic review and meta-analysis. Gastroenterol Res Pract. 2015; 17: 2015.
25. Lechowicz, K.; Drożdżal, S.; Machaj, F.; Rosik, J.; Szostak, B.; Zegan-Barańska, M.; Biernawska, J.; Dabrowski, W.; Rotter, I.; Kotfis, K. COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection. J. Clin. Med. 2020, 9, 1917.
26. Guan W. J., Ni Z. Y., Hu Y. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020 Feb 28. DOI: 10.1056/NEJMoa2002032.
27. Cai L., Cheng Z. S. et al. Быстрого советы рекомендации по диагностике и лечению синдрома Роман 2019 (2019-Н ков), инфицированных пневмонией (стандартная версия). мил. Мед. Рез. 2020. Том 7, N 1. С. 4.
28. Meng T., Cao H., Zhang H., et al. The transmembrane serine protease inhibitors are potential antiviral drugs for 2019-nCoV targeting the insertion sequence-induced viral infectivity enhancement/ Posted February 11, 2020. doi:10.1101/2020.02.08.926006
29. Winkler P., Formanek T., Mlada K et al. Increase in prevalence of current mental disorders in the context of COVID-19: analysis of repeated nationwide cross-sectional surveys. Published online by Cambridge University Press: 29 September 2020, pp. 1–17.
30. Zimmerman M, Clark H, McGonigal P, Harris L, Guzman Holst C, Martin J. Relationship between the DSM-5 anxious distress specifier and the hamilton depression rating scale anxiety/ somatization factor. J Nerv Ment Dis. 2018; 206: 152–154.
31. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020. China CDC Weekly. 2020; 2 (8): 113–22.
32. Helms, J., Kremer, S., Merdji, H., et al. Neurologic features in severe SARS-CoV-2 infection. The New England Journal of Medicine, 2020; 382 (23), 2268–2270. doi:10.1056/NEJMc2008597
Review
For citations:
Madonov P.G., Khidirova L.D., Derisheva D.A. Neuropsychiatric features of current COVID-19 pandemic (analysis of foreign publications in 2020). Medical alphabet. 2020;(33):58-61. (In Russ.) https://doi.org/10.33667/2078-5631-2020-33-58-61
Views:
382
Email this article 